Summary

Organic synthesis, nucleotide modification, oligonucleotide synthesis, Analytical Method Development, Product Development

Description

XCHEM provides services to the pharma industry for all stages of drug development, focusing on preclinical and clinical drug development efforts. We boast a team with combined experience in the pharma of over 40 years spanning API synthesis, Analytical Development and cGMP manufacturing. Charles Ogindo, PhD, who serves as the company President, has a staggering 20 years experience in all sectors of pharmaceutical drug development, while Mercells Omole, PhD, one of the Directors, has similarly extensive experience of over 13 years in Bionalytical and Analytical Method Development. Jude Ighere, PhD, is the company’s director of Materials Science division. Jude is a materials science expert that has worked for Intel for over a decade. Put together, Xchem avails tremendous amount of expertise in the pharmaceutical business space. Additional information on our capabilities is found in xchempharma.com

Special details

LC-MS, GC-MS, ICP-MS Analytical Grade solvents Raw material intermediates

Profile

  • Incorporated in
    New York
  • Established since
    2021
  • Main/Branch
    Branch

Address

Contact